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There have been a number of recent advances in the
genetic understanding of photosensitive rheumatic
diseases, especially subacute cutaneous lupus erythe-
matosus and dermatomyositis. These advances support
the concept that increased numbers of ultraviolet
light^induced apoptotic cells in skin lead to a supra-
threshold concentration of antigenic peptides. The cur-
rent genetic data suggest that increased keratinocyte
apopotosis can result from increased amounts of TNF-
a that induce apoptosis due to a ultraviolet light^sensi-
tive TNF promoter polymorphism or to decreased
clearance of apototic cells due to polymorphisms asso-
ciated with decreased serum levels of collectins such as
C1q and mannose-binding lectin.These diseases are fre-
quently oligogenic, and other yet to be elucidated genes
will, in individual patients, lead to increased numbers
of apoptotic cells associated with these cutaneous auto-
immune diseases. In the presence of speci¢c MHC class
I and II genes, antigen-presenting cells initiate a pri-
mary immune response that leads to cutaneous, and
likely systemic, autoimmune disease. Key words: der-
matomyositis/lupus erythematosus/collectins/mannose binding
lectin/photosensitivity/tumor necrosis factor-alpha. J Investig
Dermatol Symp Proc 9:57 ^63, 2004
OVERVIEW: GENETICS AND PHOTOSENSITIVE
RHEUMATIC DISEASES (FIG 1)
U
ltraviolet (UV) light is a trigger of cutaneous
lesions in several autoimmune diseases. These dis-
eases include a number of subsets of cutaneous
lupus erythematosus (LE) as well as dermatomyo-
sitis (DM). Recent studies suggest that the pre-
sence of increased numbers of apoptotic cells in SCLE (subacute
cutaneous LE) and DM skin relate, at least in part, to the presence
of genetic polymorphisms of genes that promote UV-induced
apoptosis and delay clearance of apoptotic cells. In addition, stu-
dies show that individual HLA class II genes are important in the
presentation of speci¢c antigens to antigen-presenting cells (APC,
see Table 1). Clearly, more genes will be de¢ned over time for
these two diseases, but the current evidence suggests that it is of-
ten combinations of pro-apoptotic and anticlearance genes in the
correct HLA setting that determine the risk of developing SCLE
or DM. UV is clearly a trigger for these diseases, but it remains to
be determined whether other triggers, such as infections, also
play a role in genetically predisposed individuals.
A growing number of studies based on the genetics, phototest-
ing, and serologic/pathologic testing of cutaneous photosensitive
autoimmune disease patients are con¢rming di¡erences between
the various disease subsets. This review will focus on recent ad-
vances in our understanding of the genetics and pathogenesis of
SCLE and DM, focusing on both similarities and di¡erences be-
tween these diseases, and it will contrast these ¢ndings with those
concerning other forms of photosensitive LE.
DEFINITION OF PHOTOSENSITIVE AUTOIMMUNE
DISEASES
The subsets of cutaneous LE that are commonly triggered by UV
include subacute cutaneous LE, tumid (papulomucinous) LE, dis-
coid LE (DLE), and systemic LE (SLE). SCLE and DLE are often
clinically, histologically, and immunologically distinct (David-
Bajar et al, 1992; Lee and Farris, 1999), as is tumid LE. SCLE and
DM are similar in their histologic ¢ndings as well, but usually are
distinct clinically and serologically, with anti-Ro (anti-SSA) anti-
bodies strongly associated with SCLE (Sontheimer et al, 1982).
UV and phototesting Phototesting studies in cutaneous LE
suggest that both UVA and UVB can trigger the photosensitive
forms of LE with induction of LE lesions in 63% of SCLE cases,
72% of tumid LE cases, 60% of SLE cases, and 45% of DLE
cases (Lehmann et al, 1990; Kuhn et al, 2001b). Most patients
react to both UVA and UVB, although the doses of UVA used
for most phototesting are well above the physiologic range. It is
frequently observed that there is a delayed reaction between UV
provocation and development of cutaneous LE lesions, thus
making the correlation of UV exposure with exacerbation of the
disease di⁄cult to determine for many patients (Kuhn et al,
2001a).
Apoptosis and its role in photosensitive autoimmune
diseases One of the hallmarks of cutaneous SCLE, DLE, and
DM is the presence of increased numbers of apoptotic cells in
lesional skin (Pablos et al, 1999). Recent studies suggest that UV-
induced apoptosis initiates or exacerbates autoimmunity. It
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is likely that abnormal production or abnormal clearance of UV-
induced apoptotic cells may cause a suprathreshold concentration
of nontolerized antigens that is inadequately cleared by the
relatively anti-in£ammatory macrophage pathway. Normally,
apoptotic cells are cleared very e⁄ciently, inhibiting in-
£ammation and inducing tolerance, in part because of anti-in£a-
mmatory cytokines (Huynh et al, 2002). This then allows either
the apoptotic or the necrotic cells access to the MHC class I and
II pathway of a population of APCs that can then, in the presence
of costimulatory signals and in susceptible hosts, initiate a
primary immune response, leading to autoimmunity. The exact
mechanism of development of autoimmunity is unclear, and it
is possible that ine⁄cient killing and removal of autoreactive T
and B cells, in the setting of speci¢c triggers that de¢ne the
autoantigen, cause expansion of the population of autoreactive T
cells (Pollard, 2002).
There is evidence that UV irradiation of cultured keratinocytes
causes both translocation and apoptosis of various intracellular
and intranuclear antigens to small surface blebs and apoptotic
bodies on the keratinocyte cell surface. These blebs and bodies
are enriched in 52-kDa Ro, ribosomes, calreticulin, and
phospholipid complexes (Casciola-Rosen et al, 1994; Casciola-
Rosen and Rosen, 1997), and these lupus autoantigens can be
structurally modi¢ed during apoptosis (Cacsiola-Rosen et al,
1995; Casciola-Rosen et al, 1999). Studies of T cells from
cutaneous LE blood and skin suggest evidence of an antigen-
driven response (Furukawa et al, 1996; Kita et al, 1998). The
subsequent generation of autoantibodies, such as anti-Ro/SSA
and anti-LA/SSB, recognize the cell surface of the apoptotic cell,
and this is enhanced with estrogen (LeFeber et al, 1984; Furukawa
et al, 1988; Furukawa et al, 1990). Increased autoantibody binding
to keratinocytes derived from SCLE and SLE patients has been
reported (Furukawa et al, 1999). IgG1 anti-Ro autoantibody,
demonstrated in skin and blood in SCLE patients, can
potentially activate both complement- and antibody-dependent
cellular cytotoxicity (ADCC) (Bennion et al, 1990). Basal
keratinocytes are more resistant to apoptosis and are targets of
ADCC in SCLE (Norris et al, 1997). It is likely that the inter-
action between these autoantibodies and irradiated keratinocytes
leads to cytotoxic mechanisms through ADCC (Norris et al, 1997;
Furukawa et al, 1999). In addition, cytotoxic T cells can induce
apoptosis independently. The strongest evidence that these
autoantibodies are pathogenic comes from the neonatal
equivalent of SCLE, where the neonatal skin disease resolves at
the time that maternal autoantibodies are cleared (Lee and
Farris, 1999).
Less is known about the relevance of distinct autoantibodies in
cutaneous DM, but there is evidence of activation of complement
and deposition of C5b-9 in the skin of both SCLE and DM. It is
likely that lymphocyte-mediated cytotoxicity plays a role in DM
and, possibly, in SCLE.
Apoptosis and UV light UV light triggers apoptosis through
several mechanisms, and UVA and UVB have distinct modes of
induction of the DNA damage that lead to apoptosis. Apoptosis
of keratinocytes (KC), or sunburn cells, are recognized by the
presence of pyknotic nuclei and shrunken and eosinophilic
cytoplasm. In particular, UVB causes DNA damage through
formation of thymidine dimers. It induces TNF-a via a
mechanism related to DNA damage (Kock et al, 1990; Skov et al,
1997; Kibitel et al, 1998;Werth and Zhang, 1999). TNF-a has been
shown to play an important role in UV-induced apoptosis
(Schwarz et al, 1995; Zhuang et al, 1999). UVB, through DNA
damage and possibly immunomodulatory factors such as
prostaglandins and TNF-a, induces IL-10 (Nishigori et al, 1996).
It also has e¡ects on membrane and cytoplasmic targets. One
example of this is UVB activation of death receptors, with direct
activation of FAS (Takahashi et al, 2002). UVA e¡ects are complex
and involve both early and late mechanisms, some of which are
mediated through reactive oxygen species and induction of pro-
apoptotic FasL. There is also some activation of pyrimi-
dine dimers with UVA, but UVA-1^induced apoptosis is not
inhibited by DNA repair enzymes, suggesting potential
mechanistic di¡erences between UVA and UVA-1 (Godar, 1999;
Nishigaki et al, 1999; Murphy et al, 2001; Nghiem et al, 2002).
Both UVA and UVB induce IL-1 and IL-12, but UVB appears
to selectively increase keratinocyte production of TNF-a and
IL-10 (Kondo and Jimbow, 2001; Skov et al, 1998; Werth and
Zhang, 1999;Werth et al, 2003). Thus, there are speci¢c cytokines
and mechanisms that account for some of the di¡erential e¡ects
of UVA and UVB (O’Garra and Murphy, 1993). Additional
mechanisms important in determining UV-induced apoptosis
involve the Bcl-2 regulatory family, with control pro- and anti-
apoptotic proteins located in the mitochondrial membranes.
Nitric oxide protects against keratinocyte and endothelial cell
UVA-induced apoptosis, possibly by induction of Bcl-2
(Suschek et al, 2001), but it is decreased with UVB irradiation
(Yamaoka et al, 2000).
Because UVA and UVB can induce apoptosis, it is not
surprising that both have been implicated in the induction of
LE and DM skin lesions in systematic phototesting (Lehmann et
al, 1990), although the UVA doses utilized for such testing (100
J/cm2) tend to be higher than physiologic exposures, which are
about 5 J/cm2 per hour. Clearly, irradiation of human skin with
20 J/cm2 is su⁄cient to induce signi¢cant amounts of apoptosis
(Fig 2), and primidine dimers are induced by UVA in mice at
doses of 8 J/cm2 (Nghiem et al, 2002).
Fas and FasL are increased in lesional CLE skin, and Bcl-2 is
decreased in the basal layer of the epidermis (Baima and
Sticherling, 2001). Thus, suppression of protective Bcl-2 may be
necessary prior to the Fas-induced apoptosis of basal KCs in LE
skin lesions.
Although there are several pathways for apoptosis of KCs, as
well as numerous anti-in£ammatory regulatory molecules,
studies have shown that TNF-a is a signi¢cant factor in UVB-
induced apoptosis (Schwarz et al, 1995).
The role of pro-apoptotic genes in SCLE and DM Variant
alleles associated with increased amounts of TNF-a, given the
known UV induction of TNF-a and the role of TNF-a in
inducing apoptosis, are prime candidates in the genetic patho-
Figure1. Model for pathogenesis of photosensitive autoimmune dis-
ease. Apoptotic cells are normally cleared by nonin£ammatory pathways
that involve macrophages. In the presence of a number of genetic poly-
morphisms that lead to overexpression or underexpression of proteins in-
volved in promoting apoptosis or impairing clearance of apoptotic cells,
marked with , various immune e¡ector pathways that increase apoptotic
death are triggered, as outlined in the box.
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genesis of SCLE and DM.TNF-a induces Ro and La antigen on
cultured KCs, causing increased translocation or apoptosis of
these cells (Dorner et al, 1995). The ¢rst TNF variant described
within the human TNF locus was a biallelic polymorphism
located at position ^308 of the TNF promoter region. There is a
very strong association between the uncommonTNF allele (^308
A) and the HLA-A1, -B8, and -DR3 alleles, and early studies
could not demonstrate an independent association between
the ^308 A TNF promoter polymorphism and SLE (Wilson
et al, 1993), probably because of the strong linkage dysequili-
brium seen in Caucasians between ^308 A and HLA-DR3
(Wilson et al, 1993). There is a strong association of HLA-DR3
and the presence of anti-SSA and anti-SSB autoantibodies in
SLE patients not seen with the ^308 A polymorphism alone
(Wilson et al, 1994). Studies in African Americans with SLE,
who do not exhibit linkage dysequilibrium between ^308 A
and HLA-DR3, determined the independent association of the ^
308 A promoter polymorphism with SLE (Sullivan et al, 1997),
which has subsequently been con¢rmed (Rood et al, 2000).
Reporter genes under the control of the two allelic TNF pro-
moters demonstrated that ^308 A is a much stronger transcrip-
tional activator than the ^308G wild-type promoter in a human
B cell line (Wilson et al, 1997). More recent studies demonstrated
a large increase in the ^308 A promoter polymorphism in SCLE
and a more modest but signi¢cant increase in both juvenile and
adult DM (Pachman et al, 2000; Werth et al, 2000; Werth et al,
2002b). Reporter genes under the control of the two allelic TNF
promoters demonstrated that ^308 A is a much stronger
transcriptional activator than the ^308G wild-type promoter in
UVB-irradiated, but not UVA-irradiated, keratinocytes, and the
^308 A variant is associated with increased TNF-a production in
keratinocytes (Silverberg et al, 1999;Werth et al, 2000). The initial
reported association with SCLE has been subsequently con¢rmed
in a separate cohort of SCLE patients (Millard et al, 2001).With
a total of 52 SCLE patients in our cohort to date (51 Caucasian,
1 African American), 63% are either homozygous (15%) or
heterozygous (48%) for the ^308 A TNF promoter poly-
morphism. In the Caucasian control group, 27.7% are either
homozygous (1.3%) or heterozygous (26.4%) for the ^308 A
TNF promoter polymorphism. No statistical di¡erence between
DLE and controls could be demonstrated, suggesting genetic
di¡erences between SCLE and DLE (Werth et al, 2000) and a
role for increased TNF-a in the more photosensitive SCLE.
With a total of 60 DM patients in our cohort to date (55
Caucasian, 4 African American, 1 Hispanic), 45% are either
homozygous (6.7%) or heterozygous (38.3%) for the ^308 A
TNF promoter polymorphism (Werth et al, 2002b). In the juve-
nile DM group, 48% are homozygous (26%) or heterozygous
(22%), demonstrating a higher incidence of homozygosity for
the overproducing polymorphism than in the adult DM group
(Pachman et al, 2000). In addition, the disease course was longer
in both TNFa promoter 308A heterozygous and homozygous
juvenile DM patients and more severe and therapeutically
resistant in only the 308A homozygous adult DM patients
(Pachman et al, 2000; Werth et al, 2002b). Overall, these data
demonstrate a highly signi¢cant statistical association of the
overproducing ^308A TNF promoter polymorphisms in SCLE
and juvenile and adult DM.
The role of other pro-apoptotic cytokines remains to be
de¢ned in photosensitive rheumatic diseases. There is an
association of three IL-10 SNPs with production of anti-Ro
antibodies in SLE, as well as reports of the association of
overproducing IL-10 polymorphisms with SLE (Lazarus et al,
1997; Gibson et al, 2001); however, increases in IL-10 production
were not found in cutaneous LE (van der Linden et al, 2000).
It is of interest that UV-induced immunosuppression and
tolerance induction are reversed by recombinant interleukin
(IL)-12 (Schmitt et al, 1995; Schwarz et al, 1996). IL-12 suppresses
IL-10 secretion from irradiated KCs and blunts the rise of plasma
TNF-a that typically occurs after UV irradiation (Schmitt et al,
2000). Recent studies suggest that IL-12 is induced in a dose-
responsive fashion by both UVA and UVB (Werth et al, 2003).
In addition, IL-12 blocks TNF-a secretion from irradiated KCs,
and this e¡ect is mediated mostly at the level of the TNF
promoter (Werth et al, 2003). IL-12 induces DNA repair
enzymes and inhibits KC apoptosis (Schwarz et al, 2002). It is
thus tempting to speculate that UVA-1^induced IL-12 may be
responsible for inhibition of TNF-a, possibly working through
DNA repair enzymes, and so accounts for the therapeutic e¡ects
of UVA-1 seen in particular with anti-Ro/SSA positive
photosensitive LE patients (McGrath, 1994).
Increased UV-induced epidermal cytokines, such as TNF-a,
have other rami¢cations in terms of potential contributions to
the pathogenesis of SCLE and DM. First, UV-induced
cytokines such as IL-1a and TNF-a increase keratinocyte
expression of adhesion molecules such as intracellular adhesion
molecule 1 (ICAM-1), which enhances the adhesion of T cells.
Increases in keratinocyte and endothelial cell ICAM-1 and
vascular cell adhesion molecule 1 (VCAM-1) are seen in DLE,
SCLE, tumid LE, and DM (Hausmann et al, 1996; Kuhn et al,
2002). Soluble E-selectin is increased in cutaneous LE and DM
(Nyberg and Stephansson, 1999; Nyberg et al, 1999; Kubo et al,
2000; Kuhn et al, 2002), as is soluble ICAM-1 (Kumamoto et al,
1997) and soluble VCAM-1.
CXCR3-activating chemokines (CXCL9, CXCL10, and
CXCL11) are secreted by macrophages and activated keratino-
cytes, and likely bring in£ammatory cells to the dermal^
Figure 2. Skin biopsy showing TUNEL þ apoptotic keratinocytes
in (a) UVA-irradiated skin 48 hours after irradiation (20 J/cm2), but not in
(b) sham-irradiated normal skin.
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epidermal junction and periadnexal areas in cutaneous LE. IFN-
g, secreted by activated T cells, macrophages, and UVA-irradiated
KCs, induces not only these activating chemokines but also
ICAM-1 and HLA-DR3, which are present on keratinocytes,
endothelial cells, macrophages, and most in¢ltrating T cells
(Flier et al, 2001). CXCR3 is expressed by both CD4þ and
CD8þ dermal T cells in areas where the CXCR3-activating
chemokines are present in cutaneous LE.
The role of genes related to decreased clearance of apoptotic
cells in SCLE and DM The mechanisms for phagocytosis of
apoptotic cells (ACs) are enormously complex, with several
receptors implicated in the uptake of ACs by phagocytes. These
receptors interact with their ligands on the AC either directly or
through bridging proteins (Somersan and Bhardwaj, 2001). In
apoptosis, there is exposure of phosphatidylserine on the outer
lea£et of the plasma membrane (Ho¡mann et al, 2001). Recent
data suggest that a common pathway for apoptosis involves
tethering through engagement of receptors on the phagocyte,
such as CD36, avb3, and avb5 integrins, CD14, and CD68
combined with ligation of the phosphatidylserine receptor
(Ho¡mann et al, 2001). There are phosphatidylserine-inde-
pendent pathways for phagocytosis, and these involve the
collectins. Under nonin£ammatory conditions, uptake of ACs
by macrophages is thought to suppress autoimmune responses
through production of IL-10, TGF-b, PAF, and PGE and
inhibition of proin£ammatory cytokines such as TNF-a, GM-
CSF, IL-12, IL-1b, and IL-8 (Somersan and Bhardwaj, 2001).
Under in£ammatory conditions or when phosphatidylserine
or its receptor levels are decreased, it has been proposed that
other forms of clearance, such as the collectins, dominate. C1q
and mannose-binding lectin (MBL) belong to a family of
collectins, otherwise known as defense collagens. Collectins
contain a collagen-like tail and a globular head with lectin
domains. They play a role in innate immunity, and de¢ciences
of them are associated with an increased susceptibility to
infections and autoimmunity (Hansen and Holmskov, 1998;
Ogden et al, 2001). The absence of collectins could predispose to
a redirection of apototic material away from nonin£ammatory
macrophage clearance to more proin£ammatory immature
dendritic cells (DC).
C1q binds directly and speci¢cally to surface blebs of apoptotic
human keratinocytes (Korb and Ahearn, 1997). The globular head
of C1q binds to apoptotic endothelial cells, and MBL binds to
apoptotic Jurkat T cells (Navratil et al, 2001). Recent data suggest
that the collagenous tail of C1q and MBL bind to macrophages
through calreticulin (CRT) and CD91 on the macrophage cell
surface (Ogden et al, 2001). C1q and MBL enhance macrophage
uptake of apoptotic cells, debris, and infectious organisms through
this CRT/CD91 receptor, which in turn initiates macropinocytosis
and engulfment of apoptotic cells (Guan et al, 1994; Nepomuceno et
al, 1997; Navratil et al, 2001; Ogden et al, 2001).
Growing evidence in SLE patients and autoimmune mouse
models indicates that defects in the clearance of apoptotic cells
may also be important in triggering autoimmune responses.
There is abnormal clearance of apoptotic lymphocytes and
fragments by macrophages in SLE (Hermann et al, 1998). There
is impaired uptake of apoptotic cells in macrophages in germinal
centers of some SLE patients (Baumann et al, 2002). It has been
noted that C1q-de¢cient humans have a nearly 100% chance of
developing SLE. These patients develop photosensitive eruptions
(Bowness et al, 1994). In addition, targeted disruption of the
receptor tyrosine kinase MER results in uningested apoptotic
cells in the thymus, which is associated with induction of
antinuclear antibodies (Scott, 2001).
Animal models with homozygous C1q de¢ciency develop
high titers of antinuclear antibodies and glomerulonephritis,
coupled with the accumulation of apoptotic bodies in the
glomeruli (Botto et al, 1998; Taylor et al, 2000; Mitchell et al,
2002). UV irradiation studies utilizing C57BL/6, 129/Sv, and
C57BL/6129/Sv did not demonstrate an alteration in rate of
clearance of sunburn cells after acute UV exposure, and chronic
exposure did not alter the systemic disease (Pickering et al, 2001).
More recent studies crossed these mice onto various genetic back-
grounds, and it was determined that only C1q-de¢cient MRL/
MpJ mice, but not C57BL/6-lpr/lpr or MRL/Mp-lpr/lpr strains,
had acceleration of the onset and severity of renal disease and
autoantibodies associated with an impairment in the phagocytic
clearance of apoptotic cells (Mitchell et al, 2002). UV irradiation
studies have not been reported in these mice.
SCLE was recently linked to a low-producing variant of the
C1qA gene, and it is likely that low C1q levels permit delayed
clearance of UV-induced apoptotic KCs (Racila et al, 2002). Pro-
bably, persistence of apoptotic and necrotic KCs leads to phago-
cytosis of apoptotic cells by immature DCs, which provides
antigenic peptides for MHC class I and class II presentation
(Rovere et al, 2000).
There is a parallel story developing with the role of MBL in
SLE. MBL has been recognized as a basis for opsonic defects in
children with immunode¢ciency (Sumiya et al, 1991). Recent data
suggest that it plays a role in increased susceptibility to infections
in SLE as well as in disease activity (Sullivan et al, 1996; Ip et al,
1998; Garred et al, 2001;Tsutsumi et al, 2001), although this has not
been a uniform ¢nding (Horiuchi et al, 2001).
Recent studies ¢nd low-producing MBL polymorphisms
highly enriched in photosensitive DM patients, but not in SCLE
patients, and 53% of DM patients had more than one low-
producing MBL polymorphism relative to 17% of controls
(p¼ 0.0002) (Werth et al, 2002a). Our data show MBL-binding
to apoptotic keratinocytes from UV-irradiated human skin
(Rosenbaum et al, 2003). It is likely that de¢ciencies in MBL
alter the ability of macrophages to clear apoptotic keratinocytes,
thus allowing for persistence of apoptotic cells and debris.
Suprathreshold concentrations of nontolerized antigens, in the
presence of costimulatory signals, can then gain access to the
MHC class I and II pathways of a population of antigen-
presenting cells that initiate a primary response, leading to DM.
It is unclear why MBL de¢ciency is associated with DM and not
SCLE, but this di¡erence probably relates to di¡erent
requirements for antigen presentation in DM relative to SCLE.
C3 has been shown on sunburn cells in C1q-de¢cient mice,
and it is likely that C3 opsonic fragments play a role in the
recognition and removal of sunburn cells (SBCs) in skin
(Pickering et al, 2001). C2 and C4 complement de¢ciencies, also
associated with SCLE and DM, may play a role in decreased
clearance of apoptotic cells.
Presentation of antigen from apoptotic cells Antigens must
be taken up by antigen-presenting cells via some form of
endocytic process prior to presentation to the T lymphocyte
sytem. Generally MHC class I and II molecules capture peptides
in the endoplasmic reticulum and endosome/lysosome system,
respectively. The assembly of peptides with MHC class I is
chaperoned by a number of membrane-bound (calnexin, tapsin)
and soluble (calreticulin, Erp57) endoplasmic reticulum proteins.
Phagocytosis of apoptotic cells by DCs usually triggers responses
associated with DC maturation and antigen presentation. DCs
then secrete in£ammatory and immunoregulatory cytokines and
chemokines; there is increased surface MHC, adhesion, and
costimulatory molecules, followed by the loss of phagocytic
activity and e⁄cient antigen presentation to CD4þ T cells.
The T cell clonal response to antigen can also trigger B cell
autoantibody responses. Antigen uptake and MHC class
I^restricted presentation is facilitated by heat shock proteins,
which are upregulated by heat and UV light (reviewed in Orteu
et al, 2001).
Dendritic cells and photosensitive autoimmune disease
There is reason to believe that DCs are involved in the
pathogenesis of photosensitive LE. Plasmacytoid DCs found in
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lesional LE skin may be an important source of the increased
IFN-a/b found in cutaneous LE lesions (Toro et al, 2000). In
murine models, these type I IFNs can act in an autocrine
manner to activate DCs, and neutralizing antibodies inhibit
upregulation of costimulatory molecules, secretion of IFN-g,
and T cell stimulatory activity (Montoya et al, 2002).
IL-1a and TNF-a, stimulated by UVB irradiation of
keratinocytes, promotes DC maturation and e⁄cient antigen
presentation (Cumberbatch et al, 2002). Of interest, IL-10 is
inhibitory of DC maturation and is in general anti-in£am-
matory (Moore et al, 2001).
INFLAMMATORYCELLS IN PHOTOSENSITIVE
AUTOIMMUNE DISEASE: THE LINK TOANTIGEN
PRESENTATION
The in£ammatory cells in cutaneous LE are predominantly
CD3þ , with CD4þ more prevalent than CD8þ cells. There
is selective expansion of Vb8.1 CD3þ cells in skin compared to
peripheral blood, consistent with an antigen-driven response
(Furukawa et al, 1996). Sequencing of TCR clonotypes from skin
also suggests an antigen-driven response (Kita et al, 1998). Addi-
tionally, there is evidence of active and productive antigen pre-
sentation, with the presence of B7.1 and B7.2 on antigen-
presenting cells and expression of MHC class II and CD28 by
in¢ltrating T cells in the cutaneous skin lesions of LE (Denfeld
et al, 1997). This suggests costimulation of T cells by the B7-1 or
B7-2 on APCs that interact with CD28 on T cells. T cells in cu-
taneous skin lesions of DM are predominantly CD4þ , in con-
trast to the predominant CD8þ T cells found in the blood and
muscle of myositis but not DM patients (Benveniste et al, 2001).
CXCR3 is expressed by a majority of both CD4þ and
CD8þ in¢ltrating T cells in cutaneous LE, suggesting a func-
tional interaction between locally produced keratinocyte and en-
dothelial chemokines and CXCR3-expressing T cells. Other
adhesion molecules such as ICAM-1 and E-selectin are likely also
important.
IL-10 stimulates immunoglobulin production by B cells, and
plays a major role in the pathogenesis of SLE. The role of IL-10
is less clear in photosensitive autoimmune disease, since it is
known to inhibit activation and e¡ector function of T cells,
monocytes, and macrophages (Moore et al, 2001).
Genetics of antigen presentation The anti-Ro/SSA antibody
production present in SCLE sera is in£uenced by the presence of
speci¢c HLA class II genes (Sontheimer et al, 1982; Provost and
Watson, 1993). In particular, HLA-DR3 is associated with both
SCLE and DM. Given the importance of TNF-a in photo-
induction of autoimmunity, it is likely that the linkage dysequi-
librium between the ^308 A TNF promoter polymorphism and
HLA-DR3 can explain some of this association. Recently it was
determined that the association of the ^308A TNF promoter
polymorphism with HLA-DR3 is much stronger in SCLE
(100%) versus DM (60%) or control (56%) (see Table 2) (Werth
et al, 2002b). This would suggest that Ro antigen presention,
enhanced because of increased apoptosis due to TNF-a, can, in
the context of HLA-DR3, stimulate an autoantibody response
and trigger SCLE. HLA-DR3 is seen to a lesser extent in DM
patients, who show the same linkage dyequilibrium that was
exhibited in Caucasian controls, thus suggesting that antigen
presentation in DM is not enhanced with HLA-DR3. Recent
animal experiments support the importance of HLA class II
genes in terms of T cell response to autoantigens. Mice
transgenic for DR2, DR3, and DQ8 showed stronger T and B
cell reponses to human Ro antigen than did DQ6 mice
(Paisansinsup et al, 2002). In addition, there is growing evidence
that tissue damage during an immune response primesTand/or B
lymphocytes, regardless of the speci¢city of the orginal insult,
leading to epitope spreading. This is also determined by HLA
class II genes (Paisansinsup et al, 2002).
It is likely that combinations of polymorphisms are at least in
part responsible for the majority of SCLE and DM. Individuals
who are homozygous for the ^308A TNF promoter poly-
morphism may have enough residual antigen from apoptotic cells
to trigger an immunologic response without having a clearance
defect. For many patients who are heterozygous for pro-apoptotic
polymorphisms, it is likely that combinations of pro-apoptotic
defects with apoptotic clearance defects predispose to auto-
immunity. Similarly, as seen with the MBL polymorphisms, patients
often have combinations of low-producing variants that probably
increase the likelihood of low MBL serum levels and decreased
clearance of apoptotic cells (Werth et al, 2002a). Clearly, HLA genes
will also play a role in antigen presentation and in determining the
autoantibody response to nontolerized apoptotic antigen.
The candidate gene approach has expanded the understanding of
the pathogenesis and genetic risk factors of both subacute
cutaneous lupus erythematosus and dermatomyositis. The signi¢-
cantly increased incidence of speci¢c genes that correlate with
overproduction or decreased clearance of apototic cells, along with
HLA genes involved with antigen presentation, support the
concept of the relationship between genetic and environmental
in£uences that trigger cutaneous autoimmune disease.
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